H.R. 3884 · 118th Congress · House

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

In Congress· Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Jun 7, 23
Passed House
Sep 23, 24
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.) 

Previous Versions

00Jun 7, 2023

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.) 

Action Timeline

18
  1. SEP 24, 2024•IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. SEP 23, 2024•Floor

    Mr

    Bucshon moved to suspend the rules and pass the bill, as amended.

  3. SEP 23, 2024•Floor

    Considered under suspension of the rules

    (consideration: CR H5578-5580)

    5578Yea
    5580Nay
    0NV
  4. SEP 23, 2024•Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.

  5. SEP 23, 2024•Floor

    Passed/agreed to in House

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)

  6. SEP 23, 2024•Floor

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)

  7. SEP 23, 2024•Floor

    Motion to reconsider laid on the table Agreed to without objection.

  8. AUG 25, 2023•Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.

    118Yea
    166Nay
    0NV
  9. AUG 25, 2023•Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.

    118Yea
    166Nay
    0NV
  10. AUG 25, 2023•Calendars

    Placed on the Union Calendar, Calendar No. 132.

  11. JUL 19, 2023•Committee

    Committee Consideration and Mark-up Session Held.

  12. JUL 19, 2023•Committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.

    50Yea
    0Nay
    0NV
  13. JUL 13, 2023•Committee

    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.

    28Yea
    0Nay
    0NV
  14. JUL 13, 2023•Committee

    Subcommittee Consideration and Mark-up Session Held

  15. JUN 09, 2023•Committee

    Referred to the Subcommittee on Health.

  16. JUN 07, 2023•IntroReferral

    Introduced in House

  17. JUN 07, 2023•IntroReferral

    Introduced in House

  18. JUN 07, 2023•IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

6

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Sep 24, 2024

Active

Energy and Commerce Committee

hsif00

Referred: Aug 25, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Jul 19, 2023

Active

Health Subcommittee

hsif14

Referred: Jul 13, 2023

Active

Health Subcommittee

hsif14

Referred: Jun 9, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Jun 7, 2023

Active